Board of Directors

Michael W. Bonney
Dennis A. Ausiello, M.D.
John K. Clarke
Marsha H. Fanucci
John M. Maraganore, Ph.D.
CEO, Alnylam Pharmaceuticals
Steven M. Paul M.D.
David E.I. Pyott
Paul R. Schimmel, Ph.D.
Amy W. Schulman
Phillip A. Sharp, Ph.D.
Kevin P. Starr

Stock transaction information provided by EDGAR Online. Alnylam Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.